Archives

Chirwa M, Ma R, Guallar C, Tariq S. Managing menopause in women living with HIV: A survey of primary care practitioners. Post Reprod Health 2017:2053369117712181.


Orrell C, Hagins DP, Belonosova E, Porteiro N, Walmsley S, Falcó V, et al. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study. The Lancet HIV 2017.